Advertisement

Topics

AI Platform Investment Geared Toward Boosting Personalized Meds

05:55 EDT 24 Aug 2017 | PharmPro

Amgen Ventures invests in GNS Healthcare to advance applications of its REFS causal machine learning and simulation AI platforms. The ongoing goal is to match drugs to individual patients, slow disease progression, and lower costs of care.
Contributed Author: 

Original Article: AI Platform Investment Geared Toward Boosting Personalized Meds

NEXT ARTICLE

More From BioPortfolio on "AI Platform Investment Geared Toward Boosting Personalized Meds"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...